Skip to main content

Mike Olds

Analyst

Morgan Stanley

Equibles does not estimate personal net worth.

About Mike Olds

Mike Olds is recorded as Analyst at Morgan Stanley. Mike Olds has spoken on 2 earnings calls and 1 other investor event across 3 companies, most recently for Dyne Therapeutics, Inc. on September 14, 2026. Those appearances were for Dyne Therapeutics, Inc. (DYN), Ionis Pharmaceuticals Inc (IONS) and Vir Biotechnology, Inc. (VIR). The companies whose calls Mike Olds spoke on are classified in the Healthcare sector.

Mike Olds on recent calls

“Good morning, everyone, and thanks for joining us at the Morgan Stanley Global Healthcare Conference. I'm Mike Olds. We're the biotech analysts here. It's my pleasure to introduce the team from Dyne Therapeutics.”
Analyst — Morgan Stanley, Morgan Stanley 24th Annual Global Healthcare Conference ·
“Just curious if you can give us a sense of what data we might expect at the upcoming ESC meeting, maybe in terms of endpoints, you know, level of follow-up, et cetera there.”
Analyst — Morgan Stanley, Second Quarter 2026 Financial Results Webcast ·
“Maybe just one on VIR 5500 and durability, I guess maybe just talk about your level of confidence there that some of this very strong early data that you're seeing can be sustained over a longer term.”
Analyst — Morgan Stanley, Vir Biotechnology, Inc. Q4 FY2025 Earnings Call ·

Affiliation history

  • Morgan Stanley

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity